These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22548870)

  • 1. Effects of chronic vardenafil treatment persist after end of treatment in rats with acute arteriogenic erectile dysfunction.
    Hotta Y; Ohno R; Kataoka T; Mikumo M; Takahata Y; Ohno M; Maeda Y; Kimura K
    J Sex Med; 2012 Jul; 9(7):1782-8. PubMed ID: 22548870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic vardenafil treatment improves erectile function via structural maintenance of penile corpora cavernosa in rats with acute arteriogenic erectile dysfunction.
    Hotta Y; Hattori M; Kataoka T; Ohno R; Mikumo M; Maeda Y; Kimura K
    J Sex Med; 2011 Mar; 8(3):705-11. PubMed ID: 21143425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral L-citrulline supplementation improves erectile function in rats with acute arteriogenic erectile dysfunction.
    Shiota A; Hotta Y; Kataoka T; Morita M; Maeda Y; Kimura K
    J Sex Med; 2013 Oct; 10(10):2423-9. PubMed ID: 23844604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of regular use of vardenafil on endothelial and erectile functions in patients with arteriogenic erectile dysfunction].
    Gamidov SI; Shcherbakov DV; Tkhagapsoeva RA; Koroteev RV
    Ter Arkh; 2009; 81(10):70-3. PubMed ID: 19947446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vardenafil and resveratrol synergistically enhance the nitric oxide/cyclic guanosine monophosphate pathway in corpus cavernosal smooth muscle cells and its therapeutic potential for erectile dysfunction in the streptozotocin-induced diabetic rat: preliminary findings.
    Fukuhara S; Tsujimura A; Okuda H; Yamamoto K; Takao T; Miyagawa Y; Nonomura N; Okuyama A
    J Sex Med; 2011 Apr; 8(4):1061-71. PubMed ID: 21269399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of phosphodiesterase type 5 inhibitor treatment in men with erectile dysfunction and dyslipidemia: a post hoc analysis of the vardenafil statin study.
    Miner MM; Barnes A; Janning S
    J Sex Med; 2010 May; 7(5):1937-47. PubMed ID: 20202105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vardenafil improves penile erection in type 2 diabetes mellitus patients with erectile dysfunction: role of tropomyosin.
    Zamorano-León JJ; Olivier C; de Las Heras N; Mateos-Cáceres PJ; Brime Menéndez R; Rodríguez-Sierra P; Martín Palacios N; Manso LS; Modrego J; Segura A; Macaya C; López-Farré AJ
    J Sex Med; 2013 Dec; 10(12):3110-20. PubMed ID: 24112450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vardenafil improves erectile function in men with erectile dysfunction and associated underlying conditions, irrespective of the use of concomitant medications.
    Eardley I; Lee JC; Shabsigh R; Dean J; Maggi M; Neuser D; Norenberg C
    J Sex Med; 2010 Jan; 7(1 Pt 1):244-55. PubMed ID: 20104672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo and in vitro response of corpus cavernosum to phosphodiesterase-5 inhibition in the hypercholesterolaemic rabbit.
    Firoozi F; Longhurst PA; White MD
    BJU Int; 2005 Jul; 96(1):164-8. PubMed ID: 15963142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing the dose of vardenafil on a daily basis does not improve erectile function after unilateral nerve-sparing radical prostatectomy.
    Bannowsky A; van Ahlen H; Loch T
    J Sex Med; 2012 May; 9(5):1448-53. PubMed ID: 22462626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P144, A TGF-β1 antagonist peptide, synergizes with sildenafil and enhances erectile response via amelioration of cavernosal fibrosis in diabetic rats.
    Li WJ; Wang H; Zhou J; Li B; Zhang J; Lu M; Wang Z
    J Sex Med; 2013 Dec; 10(12):2942-51. PubMed ID: 24134744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ENDOTRIAL study: a spontaneous, open-label, randomized, multicenter, crossover study on the efficacy of sildenafil, tadalafil, and vardenafil in the treatment of erectile dysfunction.
    Jannini EA; Isidori AM; Gravina GL; Aversa A; Balercia G; Bocchio M; Boscaro M; Carani C; Corona G; Fabbri A; Foresta C; Forti G; Francavilla S; Granata AR; Maggi M; Mansani R; Palego P; Spera G; Vetri M; Lenzi A;
    J Sex Med; 2009 Sep; 6(9):2547-60. PubMed ID: 19570039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial rehabilitation: the impact of chronic PDE5 inhibitors on erectile function and protein alterations in cavernous tissue of diabetic rats.
    De Young LX; Domes T; Lim K; Carson J; Brock GB
    Eur Urol; 2008 Jul; 54(1):213-20. PubMed ID: 18342431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in sexual quality of life of the female partner following vardenafil treatment of men with erectile dysfunction: a randomized, double-blind, placebo-controlled study.
    Martín-Morales A; Graziottin A; Jaoudé GB; Debruyne F; Buvat J; Beneke M; Neuser D
    J Sex Med; 2011 Oct; 8(10):2831-40. PubMed ID: 21679304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effects of BAY 60-4552 and vardenafil on relaxation of corpus cavernosum tissue of patients with erectile dysfunction and clinical phosphodiesterase type 5 inhibitor failure.
    Albersen M; Linsen L; Tinel H; Sandner P; Van Renterghem K
    J Sex Med; 2013 May; 10(5):1268-77. PubMed ID: 23421435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment of erectile dysfunction with a phosphodiesterase-5 inhibitor and dose optimization based on nocturnal penile tumescence.
    Mathers MJ; Klotz T; Brandt AS; Roth S; Sommer F
    BJU Int; 2008 May; 101(9):1129-34. PubMed ID: 18190629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of vardenafil for the treatment of erectile dysfunction in men with metabolic syndrome: results of a randomized, placebo-controlled trial.
    Schneider T; Gleissner J; Merfort F; Hermanns M; Beneke M; Ulbrich E
    J Sex Med; 2011 Oct; 8(10):2904-11. PubMed ID: 21771281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of BAY 60-4552 and vardenafil exerts proerectile facilitator effects in rats with cavernous nerve injury: a proof of concept study for the treatment of phosphodiesterase type 5 inhibitor failure.
    Oudot A; Behr-Roussel D; Poirier S; Sandner P; Bernabé J; Alexandre L; Giuliano F
    Eur Urol; 2011 Nov; 60(5):1020-6. PubMed ID: 21839578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of icariin on the erectile function and expression of nitrogen oxide synthase isoforms in corpus cavernosum of arterigenic erectile dysfunction rat model].
    Tian L; Xin ZC; Liu WJ; Yang YM; Liu G; Chen L; Fu J; Wang LL
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):954-7. PubMed ID: 15329286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the clinical efficacy of vardenafil correlate with its effect on the endothelial function of cavernosal arteries? A pilot study.
    Mazo EB; Gamidov SI; Iremashvili VV
    BJU Int; 2006 Nov; 98(5):1054-8. PubMed ID: 17034606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.